Suppr超能文献

基于网络药理学的葛根芩连汤抗糖尿病机制分析与实验探究

Network Pharmacology-Based Analysis and Experimental Exploration of Antidiabetic Mechanisms of Gegen Qinlian Decoction.

作者信息

Xu Yu, Huang Jihan, Wang Ning, Tan Hor-Yue, Zhang Cheng, Li Sha, Tang Guoyi, Feng Yibin

机构信息

School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.

Center for Drug Clinical Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

出版信息

Front Pharmacol. 2021 Jul 26;12:649606. doi: 10.3389/fphar.2021.649606. eCollection 2021.

Abstract

Type-2 diabetes mellitus (T2DM) and therapy options have been studied increasingly due to their rising incidence and prevalence. The trend of applying traditional Chinese medicine (TCM) to treat T2DM is increasing as a crucial medical care for metabolic dysfunctions. Gegen Qinlian decoction (GQL), a well-known classical TCM formula used in China, has been clinically applied to treat various types of chronic metabolic diseases. However, antidiabetic effects of GQL administration during T2DM have never been studied systematically. We assessed physiological and molecular targets associated with therapeutic effects of GQL by evaluating network topological characteristics. The GQL-related biological pathways are closely associated with antidiabetic effects, including the TNF and PI3K-AKT signaling pathways. Associated primary biological processes such as RNA polymerase II promoter transcription participate in the inflammatory response, oxidative stress reduction, and glucose metabolic process, thereby exerting multiple biological effects on the antidiabetic mechanism. Furthermore, our results showed that GQL can affect blood glycemic levels and ameliorate inflammatory symptoms, and liver and pancreas tissue injury in high-fat diet plus streptozotocin-induced diabetic mice. and experiments confirmed that antidiabetic effects of GQL were associated with a modulation of the TNF and PI3K-AKT-MTOR pathways.

摘要

由于2型糖尿病(T2DM)的发病率和患病率不断上升,对其及治疗方案的研究日益增多。将传统中医(TCM)应用于治疗T2DM的趋势正在增加,作为对代谢功能障碍的关键医疗手段。葛根芩连汤(GQL)是中国一种著名的经典中药方剂,已在临床上用于治疗各种类型的慢性代谢疾病。然而,GQL在T2DM治疗期间的抗糖尿病作用从未被系统研究过。我们通过评估网络拓扑特征来评估与GQL治疗效果相关的生理和分子靶点。与GQL相关的生物途径与抗糖尿病作用密切相关,包括TNF和PI3K-AKT信号通路。相关的主要生物学过程如RNA聚合酶II启动子转录参与炎症反应、氧化应激降低和葡萄糖代谢过程,从而对抗糖尿病机制发挥多种生物学作用。此外,我们的结果表明,GQL可以影响血糖水平,改善高脂饮食加链脲佐菌素诱导的糖尿病小鼠的炎症症状以及肝脏和胰腺组织损伤。 实验证实,GQL的抗糖尿病作用与TNF和PI3K-AKT-MTOR途径的调节有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55d1/8350346/fb1f6f555baa/fphar-12-649606-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验